HLS Therapeutics (TSE:HLS - Free Report) had its price target lifted by Stifel Nicolaus from C$3.50 to C$4.00 in a report published on Wednesday,BayStreet.CA reports. Stifel Nicolaus currently has a hold rating on the stock.
HLS Therapeutics Price Performance
Shares of HLS traded up C$0.14 during trading hours on Wednesday, hitting C$4.66. 6,300 shares of the stock were exchanged, compared to its average volume of 14,753. The stock's 50-day moving average price is C$4.19 and its two-hundred day moving average price is C$3.82. HLS Therapeutics has a 12-month low of C$3.00 and a 12-month high of C$5.48. The company has a debt-to-equity ratio of 86.50, a quick ratio of 1.01 and a current ratio of 1.56. The company has a market cap of C$103.67 million, a price-to-earnings ratio of -4.67 and a beta of 1.07.
About HLS Therapeutics
(
Get Free Report)
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris.
Featured Stories
Before you consider HLS Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HLS Therapeutics wasn't on the list.
While HLS Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
